Analysts Split On How To Read Intercept Switching Clinical Trial Endpoints
February 13, 2017 at 11:47 AM EST
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) hosted a call on Friday to divulge information about changes it made to a late-stage ...